AllianceBernstein’s AbbVie ABBV Stock Holding History

AllianceBernstein’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.24B	Sell	5,416,509 -1,293,432	-19%	-$287M	0.4%	45
2025 Q4	$1.53B	Sell	6,709,941 -571,386	-8%	-$130M	0.48%	33
2025 Q3	$1.69B	Buy	7,281,327 +1,758,657	+32%	+$358M	0.53%	30
2025 Q2	$1.03B	Buy	5,522,670 +1,234,884	+29%	+$230M	0.33%	54
2025 Q1	$898M	Sell	4,287,786 -686,845	-14%	-$134M	0.33%	58
2024 Q4	$884M	Buy	4,974,631 +50,243	+1%	+$9.24M	0.3%	63
2024 Q3	$972M	Buy	4,924,388 +190,087	+4%	+$35.5M	0.33%	58
2024 Q2	$812M	Sell	4,734,301 -160,901	-3%	-$26.7M	0.28%	66
2024 Q1	$891M	Buy	4,895,202 +701,455	+17%	+$121M	0.32%	61
2023 Q4	$650M	Buy	4,193,747 +86,936	+2%	+$12.7M	0.25%	84
2023 Q3	$612M	Sell	4,106,811 -174,299	-4%	-$25.6M	0.26%	78
2023 Q2	$577M	Buy	4,281,110 +287,276	+7%	+$42.1M	0.24%	85
2023 Q1	$636M	Buy	3,993,834 +4,097	+0.1%	+$626K	0.27%	79
2022 Q4	$645M	Buy	3,989,737 +115,439	+3%	+$17.7M	0.29%	83
2022 Q3	$520M	Sell	3,874,298 -7,540	-0.2%	-$1.08M	0.25%	88
2022 Q2	$595M	Buy	3,881,838 +330,490	+9%	+$50.5M	0.27%	80
2022 Q1	$576M	Buy	3,551,348 +430,787	+14%	+$62.6M	0.22%	86
2021 Q4	$423M	Buy	3,120,561 +275,034	+10%	+$32.5M	0.15%	125
2021 Q3	$307M	Buy	2,845,527 +327,105	+13%	+$37.4M	0.12%	159
2021 Q2	$284M	Sell	2,518,422 -212,935	-8%	-$24M	0.11%	170
2021 Q1	$296M	Sell	2,731,357 -299,518	-10%	-$32M	0.13%	154
2020 Q4	$325M	Buy	3,030,875 +105,761	+4%	+$10.2M	0.15%	116
2020 Q3	$256M	Sell	2,925,114 -3,197	-0.1%	-$301K	0.14%	130
2020 Q2	$288M	Buy	2,928,311 +325,062	+12%	+$28.6M	0.17%	117
2020 Q1	$198M	Sell	2,603,249 -43,458	-2%	-$3.7M	0.14%	137
2019 Q4	$234M	Sell	2,646,707 -267,988	-9%	-$22.2M	0.13%	141
2019 Q3	$221M	Buy	2,914,695 +63,064	+2%	+$4.32M	0.14%	142
2019 Q2	$207M	Buy	2,851,631 +73,647	+3%	+$5.79M	0.13%	151
2019 Q1	$224M	Sell	2,777,984 -100,845	-4%	-$8.25M	0.15%	138
2018 Q4	$265M	Sell	2,878,829 -53,638	-2%	-$4.72M	0.2%	108
2018 Q3	$277M	Sell	2,932,467 -726,236	-20%	-$68.9M	0.18%	114
2018 Q2	$339M	Sell	3,658,703 -228,235	-6%	-$22.3M	0.24%	93
2018 Q1	$368M	Sell	3,886,938 -1,417,376	-27%	-$156M	0.27%	88
2017 Q4	$513M	Sell	5,304,314 -163,683	-3%	-$15.4M	0.37%	65
2017 Q3	$486M	Buy	5,467,997 +1,757,356	+47%	+$134M	0.36%	66
2017 Q2	$269M	Sell	3,710,641 -42,488	-1%	-$2.86M	0.21%	113
2017 Q1	$245M	Buy	3,753,129 +129,905	+4%	+$8.17M	0.19%	115
2016 Q4	$227M	Sell	3,623,224 -1,003,321	-22%	-$61.2M	0.19%	116
2016 Q3	$292M	Buy	4,626,545 +442,163	+11%	+$28.6M	0.25%	97
2016 Q2	$259M	Sell	4,184,382 -140,857	-3%	-$8.58M	0.22%	109
2016 Q1	$247M	Sell	4,325,239 -835,921	-16%	-$46.6M	0.21%	117
2015 Q4	$306M	Buy	5,161,160 +243,350	+5%	+$14M	0.26%	96
2015 Q3	$268M	Buy	4,917,810 +251,424	+5%	+$16.4M	0.23%	100
2015 Q2	$314M	Buy	4,666,386 +1,775,713	+61%	+$116M	0.26%	90
2015 Q1	$169M	Sell	2,890,673 -15,042	-0.5%	-$909K	0.14%	156
2014 Q4	$190M	Sell	2,905,715 -21,136	-0.7%	-$1.33M	0.16%	145
2014 Q3	$169M	Sell	2,926,851 -112,925	-4%	-$6.27M	0.14%	155
2014 Q2	$172M	Sell	3,039,776 -27,230	-0.9%	-$1.43M	0.14%	160
2014 Q1	$158M	Buy	3,067,006 +55,798	+2%	+$2.82M	0.14%	178
2013 Q4	$159M	Sell	3,011,208 -36,521	-1%	-$1.79M	0.14%	167
2013 Q3	$136M	Sell	3,047,729 -81,835	-3%	-$3.63M	0.13%	165
2013 Q2	$129M	Buy	+3,129,564	New	+$137M	0.14%	157

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein's ABBV Position: Q1 2026 in Review

AllianceBernstein reduced its AbbVie (ABBV) stake by 19% in Q1 2026, selling an estimated $287M and leaving 5,416,509 shares worth $1.24B. The position accounts for 0.4% of the portfolio, ranked #45.

AllianceBernstein first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.69B in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

AllianceBernstein held 5,416,509 shares of AbbVie worth $1.24B as of Q1 2026.
AllianceBernstein sold 1,293,432 AbbVie shares in Q1 2026, an estimated $287M.
AbbVie made up 0.4% of AllianceBernstein's portfolio in Q1 2026, its #45 holding.
AllianceBernstein first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
AllianceBernstein's AbbVie position peaked at $1.69B in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.